Devimistat in combination with high dose cytarabine and mitoxantrone compared with high dose cytarabine and mitoxantrone in older patients with relapsed/refractory acute myeloid leukemia: ARMADA 2000 Phase III study

Future Oncology, Ahead of Print.

Source: Future Oncology - September 11, 2019 Category: Cancer & Oncology Authors: Timothy S Pardee Sanjeev Luther Marc Buyse Bayard L Powell Jorge Cortes Source Type: research